Highlights Wockhardt Limited

Equities

WOCKPHARMA

INE049B01025

Market Closed - NSE India S.E. Other stock markets 07:43:50 2024-05-10 EDT			5-day change	1st Jan Change
531.1 ^INR	+0.04%		-4.33%	+25.16%

04-03	Wockhardt Limited Announces Cessation of Independent Directors	CI
02-14	Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Wockhardt Limited Announces Successful Completion of Pivotal Phase 3 Pneumonia Study of Its Macrolide Antibody Nafithromycin WCK 4873	12-11	CI
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Wockhardt Trims Consolidated Loss in Fiscal Q4	23-05-29	MT
Wockhardt Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-26	CI
Wockhardt Widens Consolidated Net Profit in Fiscal Q3	23-02-14	MT
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Wockhardt Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-04	CI
Wockhardt Announces Successful Initiation of Global Phase 3 Clinical Study of Its Novel Antibiotic WCK 5222	22-08-15	CI
Wockhardt Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-12	CI
Wockhardt Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-30	CI
Wockhardt Ties Up With Serum Institute of India for Vaccine Manufacturing in UK	22-03-20	MT
Rights Issue: 3 new shares @ 225 INR for 10 existing shares	22-03-07	FA
Wockhardt Sets March 9 as Record Date for $98 Million Rights Issue	22-03-04	MT
Wockhardt Gets CDSCO Nod for Exporting Up to 100 Million Doses of Sputnik Vaccines	22-02-07	CI
Wockhardt Turns to Loss in Fiscal Q3	22-01-27	MT
Wockhardt Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-01-27	CI
Wockhardt Gets Board Nod to Raise Up To $135 Million Via Rights Issue	22-01-06	MT
Wockhardt to Acquire Remaining Stake in Subsidiary Wockhardt Biologics	21-11-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Wockhardt Limited

Equities

WOCKPHARMA

INE049B01025

Highlights

Filters